NZ241975A - Crystalline ciclosporin forms for pulmonary administration - Google Patents

Crystalline ciclosporin forms for pulmonary administration

Info

Publication number
NZ241975A
NZ241975A NZ241975A NZ24197592A NZ241975A NZ 241975 A NZ241975 A NZ 241975A NZ 241975 A NZ241975 A NZ 241975A NZ 24197592 A NZ24197592 A NZ 24197592A NZ 241975 A NZ241975 A NZ 241975A
Authority
NZ
New Zealand
Prior art keywords
particulate form
pharmaceutical composition
iii
spheroidal
ciclosporin
Prior art date
Application number
NZ241975A
Other languages
English (en)
Inventor
John Morley
Andreas Rummelt
Martin List
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ241975A publication Critical patent/NZ241975A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ241975A 1991-03-18 1992-03-16 Crystalline ciclosporin forms for pulmonary administration NZ241975A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919105705A GB9105705D0 (en) 1991-03-18 1991-03-18 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
NZ241975A true NZ241975A (en) 1994-04-27

Family

ID=10691762

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ241975A NZ241975A (en) 1991-03-18 1992-03-16 Crystalline ciclosporin forms for pulmonary administration

Country Status (29)

Country Link
US (1) US5719123A (cg-RX-API-DMAC7.html)
EP (1) EP0504760B1 (cg-RX-API-DMAC7.html)
JP (1) JP2549794B2 (cg-RX-API-DMAC7.html)
KR (1) KR920017644A (cg-RX-API-DMAC7.html)
AT (1) AT404553B (cg-RX-API-DMAC7.html)
AU (1) AU658172B2 (cg-RX-API-DMAC7.html)
CA (1) CA2063106C (cg-RX-API-DMAC7.html)
CH (1) CH685229A5 (cg-RX-API-DMAC7.html)
CZ (1) CZ281260B6 (cg-RX-API-DMAC7.html)
DE (1) DE4208258B4 (cg-RX-API-DMAC7.html)
DK (1) DK0504760T3 (cg-RX-API-DMAC7.html)
ES (1) ES2093130T3 (cg-RX-API-DMAC7.html)
FI (1) FI921125A7 (cg-RX-API-DMAC7.html)
FR (1) FR2674249A1 (cg-RX-API-DMAC7.html)
GB (2) GB9105705D0 (cg-RX-API-DMAC7.html)
GR (1) GR3021497T3 (cg-RX-API-DMAC7.html)
HU (1) HU208492B (cg-RX-API-DMAC7.html)
IE (1) IE67627B1 (cg-RX-API-DMAC7.html)
IL (1) IL101244A (cg-RX-API-DMAC7.html)
IT (1) IT1255040B (cg-RX-API-DMAC7.html)
LU (1) LU88087A1 (cg-RX-API-DMAC7.html)
MX (1) MX9201141A (cg-RX-API-DMAC7.html)
NO (1) NO310754B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ241975A (cg-RX-API-DMAC7.html)
RU (1) RU2098122C1 (cg-RX-API-DMAC7.html)
SA (1) SA92120536B1 (cg-RX-API-DMAC7.html)
SK (1) SK279576B6 (cg-RX-API-DMAC7.html)
TW (1) TW215901B (cg-RX-API-DMAC7.html)
ZA (1) ZA921987B (cg-RX-API-DMAC7.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5837677B2 (ja) * 1981-01-13 1983-08-17 松下電器産業株式会社 誘導加熱調理器
JPH07111905B2 (ja) * 1987-07-23 1995-11-29 株式会社東芝 誘導加熱調理器の負荷適否検知回路
ES2177544T3 (es) * 1992-06-12 2002-12-16 Teijin Ltd Polvo ultrafinno para inhalar y metodo para su preparacion.
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
WO1998001147A1 (en) * 1996-07-08 1998-01-15 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
US6517860B1 (en) 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
US5898028A (en) * 1997-03-20 1999-04-27 Novo Nordisk A/S Method for producing powder formulation comprising an insulin
TW581681B (en) * 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
US20020006901A1 (en) * 1999-02-05 2002-01-17 Aldo T. Iacono Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
FI20002217L (fi) * 1999-12-30 2001-07-01 Orion Yhtymae Oyj Inhalaatiopartikkelit
FI20010115A0 (fi) * 2001-01-18 2001-01-18 Orion Corp Menetelmä nanopartikkelien valmistamiseksi
RU2203064C2 (ru) * 2001-03-11 2003-04-27 Каменев Виктор Федорович Способ лечения аспириновой бронхиальной астмы
DE60233150D1 (de) * 2001-10-19 2009-09-10 Isotechnika Inc Neue cyclosporin-analoge mikroemulsionsvorkonzentrate
WO2004069223A2 (en) * 2003-02-06 2004-08-19 Cipla Ltd Pharmaceutical compositions comprising immunosuppressants and uses thereof
DK1610878T3 (da) * 2003-02-21 2014-12-01 Univ Bath Fremgangsmåde til fremstilling af partikler
US20050059583A1 (en) * 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US20060078623A1 (en) * 2004-08-13 2006-04-13 Emisphere Technologies, Inc. Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
US7827042B2 (en) * 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US7927787B2 (en) * 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US8340944B2 (en) * 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US20070124219A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US8068991B2 (en) * 2005-11-30 2011-11-29 The Invention Science Fund I, Llc Systems and methods for transmitting pathogen related information and responding
US8000981B2 (en) 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US20070174128A1 (en) * 2005-11-30 2007-07-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
DE102006051512A1 (de) 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
US20070219127A1 (en) * 2006-03-20 2007-09-20 Walt John G Cyclosporin a compositions
EP3521302A1 (en) * 2011-05-27 2019-08-07 Allergan, Inc. A new crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
JO3410B1 (ar) 2011-06-07 2019-10-20 Otsuka Pharma Co Ltd تركيبة أريبيبرازول مجفف بالتبريد
BR112014011768A2 (pt) * 2011-11-15 2017-05-09 Allergan Inc forma 2 de ciclosporina a e método de produção da mesma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203564B (en) * 1987-12-21 1991-08-28 Sandoz Ag Process for producing new orthorombos cyclosporin without solvatation
CH679119A5 (cg-RX-API-DMAC7.html) * 1988-05-13 1991-12-31 Sandoz Ag
GB8916901D0 (en) * 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
AU1294092A (en) 1992-09-24
FR2674249B1 (cg-RX-API-DMAC7.html) 1995-05-12
HU208492B (en) 1993-11-29
JPH0585940A (ja) 1993-04-06
IE67627B1 (en) 1996-04-17
RU2098122C1 (ru) 1997-12-10
ATA53492A (de) 1998-05-15
IL101244A0 (en) 1992-11-15
DK0504760T3 (da) 1996-12-23
IE920839A1 (en) 1992-09-23
DE4208258B4 (de) 2007-07-12
LU88087A1 (fr) 1993-10-27
DE4208258A1 (de) 1992-09-24
SK279576B6 (sk) 1999-01-11
ZA921987B (en) 1993-09-20
AT404553B (de) 1998-12-28
NO310754B1 (no) 2001-08-27
GB2253853B (en) 1995-04-26
GR3021497T3 (en) 1997-01-31
IL101244A (en) 1996-10-31
AU658172B2 (en) 1995-04-06
GB2253853A (en) 1992-09-23
GB9205554D0 (en) 1992-04-29
ITRM920181A0 (it) 1992-03-17
NO921012D0 (no) 1992-03-16
GB9105705D0 (en) 1991-05-01
HUT61324A (en) 1992-12-28
EP0504760A1 (en) 1992-09-23
FI921125L (fi) 1992-09-19
ITRM920181A1 (it) 1993-09-17
EP0504760B1 (en) 1996-10-09
MX9201141A (es) 1992-10-01
SA92120536B1 (ar) 2005-04-27
CA2063106A1 (en) 1992-09-19
KR920017644A (ko) 1992-10-21
CH685229A5 (de) 1995-05-15
ES2093130T3 (es) 1996-12-16
FI921125A7 (fi) 1992-09-19
US5719123A (en) 1998-02-17
TW215901B (cg-RX-API-DMAC7.html) 1993-11-11
CZ281260B6 (cs) 1996-07-17
HU9200735D0 (en) 1992-05-28
JP2549794B2 (ja) 1996-10-30
FI921125A0 (fi) 1992-03-16
CA2063106C (en) 2002-12-17
FR2674249A1 (fr) 1992-09-25
NO921012L (no) 1992-09-21
CS78592A3 (en) 1992-10-14
IT1255040B (it) 1995-10-13

Similar Documents

Publication Publication Date Title
NZ241975A (en) Crystalline ciclosporin forms for pulmonary administration
US4675189A (en) Microencapsulation of water soluble active polypeptides
EP1025840A3 (en) Oral drug compositions and methods
KR100401119B1 (ko) 택산계열유도체-기본약학조성물
BR9714015A (pt) Formulações farmacêuticas para distribuição de droga prolongada
WO1997049373A3 (en) Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin
AR007715A1 (es) Formulacion acuosa estable de un peptido, un metodo para preparar la misma y su uso para tratamiento
CA2252535A1 (en) A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
JPH0440329B2 (cg-RX-API-DMAC7.html)
HUT59940A (en) Process for producing decapeptides antagonizing releasing hormone of lutheinizing hormone and pharmaceutical compositions containing them as active components
ES8708185A1 (es) Un procedimiento para la preparacion de una emulsion de lipidos.
KR950703987A (ko) G-csf의 안정한 동결건조된 약제학적 제제(stable lyophilized pharma ceutical preparations g-csf)
ES2132170T3 (es) Composicion de esteres de l-dopa.
KR890009975A (ko) 신규의 시클로스포린 결정 형태, 이것의 제조방법 및 이것을 함유한 약학 조성물 및 그 용도
CA1188218A (en) PURIFIED ANTINEOPLASTIC FRACTIONS AND METHODS OF TREATMENT OF NEOPLASMS
KR950700326A (ko) 파라토르몬 단편, 이것의 제조방법 및 이것을 함유하는 약제(parathyroid hormone fragments, their preparation and medicaments containing the same)
KR900015749A (ko) 인터루킨-1제형
EP0657170B1 (de) Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
KR970706305A (ko) 성장 호르몬의 분비를 촉진할 수 있는 d-2-알킬트립토판을 함유하는 폴리펩티드 화합물(polypeptide compounds containing d-2-alkyltrytophan capable of promoting the release of growth hormone)
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду
CN106309358A (zh) 含有人甲状旁腺激素的药物组合物及其制备方法与用途
WO2005018657A3 (en) NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
CO4750645A1 (es) Metodo de preparacion de granulos que incorporan un medica- mento para uso farmaceutico
AR036591A1 (es) Uso de la hl en hiperestimulacion ovarica controlada
ATE233105T1 (de) Pharmazeutische zubereitung für die intravenöse oder intramuskuläre verabreichung von octreotid